FAB PHARMA SAS has a total of 30 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NHWA PHARMA CORP, YAMANOUCHI PHARMA CO LTD and ORE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Israel | 3 | |
#6 | Brazil | 2 | |
#7 | Hong Kong | 2 | |
#8 | Republic of Korea | 2 | |
#9 | New Zealand | 2 | |
#10 | United States | 2 | |
#11 | South Africa | 2 | |
#12 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Gerusz Vincent | 24 |
#2 | Denis Alexis | 17 |
#3 | Oxoby Mayalen | 17 |
#4 | Escaich Sonia | 10 |
#5 | Faivre Fabien | 7 |
#6 | Bonvin Yannick | 7 |
#7 | Van Dycke Frederic | 5 |
#8 | Ameye Dieter | 5 |
#9 | Mouzé Coralie | 3 |
#10 | Mouze Coralie | 3 |
Publication | Filing date | Title |
---|---|---|
IL244316D0 | Novel drug formulation | |
KR20160048922A | Novel drug formulation | |
US2015065416A1 | Novel drug combination | |
GB201400951D0 | Novel drug formulation | |
WO2015028104A1 | Novel drug combination | |
BR112012011793A2 | "heterocyclic acrylamides and their use as pharmaceuticals" | |
WO2011048153A1 | Novel acylpiperazinones and their use as pharmaceuticals | |
AU2009352134A1 | Novel antibacterial hydroxyphenyl compound |